Luis A. Díaz

113.3k citations

419 papers · 40.3k indexed · 21 hit papers · h-index 84

Impact in

Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.01%
- Autoimmune Bullous Skin Diseases
- Genetic factors in colorectal cancer

Papers in

Pathology and Forensic Medicine 255
- Autoimmune Bullous Skin Diseases 170
- Genetic factors in colorectal cancer 78
Genetics 114
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 108

Co-authors: Bert Vogelstein Kenneth W. Kinzler Victor E. Velculescu Nickolas Papadopoulos Shibin Zhou Alberto Bardelli Grant J. Anhalt George J. Giudice
Journals: Journal of Clinical Oncology (72 papers)Journal of Investigative Dermatology (43 papers)Journal of Clinical Investigation (18 papers)The Journal of Immunology (14 papers)Annals of Oncology (14 papers)
Partner nations: United States Brazil Japan

In The Last Decade

Luis A. Díaz

402 papers receiving 39.6k citations

Hit Papers

15 papers align trajectories log scale

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study 2022 · 501 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 The Lancet Oncology
2019 Nature Reviews Gastroenterology & Hepatology
2015 Journal of Clinical Oncology
2015 Annals of Oncology
2014 Journal of Clinical Oncology
2014 Proceedings of the National Academy of Sciences
2013 Science
2013 eLife
2012 Nature
2012 Science Translational Medicine
2011 Science Translational Medicine
2011 Science
2010 Science
2009 Science
2008 Nature Medicine
2006 Proceedings of the National Academy of Sciences
2005 Proceedings of the National Academy of Sciences
2005 Cancer Cell
1993 Journal of Clinical Investigation
1986 The Journal of Immunology
1982 New England Journal of Medicine

Peers

Countries citing papers authored by Luis A. Díaz

Since Specialization

Citations

This map shows the geographic impact of Luis A. Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis A. Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis A. Díaz more than expected).

Fields of papers citing papers by Luis A. Díaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis A. Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis A. Díaz. The network helps show where Luis A. Díaz may publish in the future.

Co-authors

The 25 scholars most cited alongside Luis A. Díaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luis A. Díaz Line = papers co-authored together Luis A. Díaz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study Annals of Oncology ·Natalia Skuza, Thierry André, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, C.J.A. Punt, Denis Smith, Rocio García‐Carbonero, Julia Alcaide, Peter Gibbs, Christelle de la Fouchardière, Fernando Rivera, Hanako Aoki, Dung T. Le, Takayuki Yoshino, Yu Zuo, 达洲, David E. Adelberg, Luis A. Díaz	2023	12
2	O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer Annals of Oncology ·Thierry André, Kai‐Keen Shiu, Yuwei Tu, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J.A. Punt, Denis Smith, Rocio García‐Carbonero, Julia Alcaide, Peter Gibbs, Christelle de la Fouchardière, F. Rivera Herrero, Elena Élez, Johanna C. Bendell, Dung T. Le, Takayuki Yoshino, R.W. Gibbens, David R. Fogelman, Patricia Marinello, Luis A. Díaz	2021	1
3	Chemotherapy and COVID-19 Outcomes in Patients With Cancer Journal of Clinical Oncology ·Justin Jee, Michael B. Foote, Melissa Lumish, Aaron J. Stonestrom, Beatriz Wills, Varun Narendra, Viswatej Avutu, Yonina R. Murciano‐Goroff, Jason E. Chan, Andriy Derkach, John Philip, Rimma Belenkaya, Agatha Gracia, Molly Maloy, Adam Watson, Chris Fong, Yelena Y. Janjigian, Luis A. Díaz, Kelly L. Bolton, Melissa S. Pessin	2020	173
4	Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy Cancer Immunology Research ·Nicolás J. Llosa, Brandon Luber, Nicholas Siegel, Pezeshki MahboobLessan, Brage Sundstrom, Qingfeng Zhu, Bjarne R. Bartlett, Laveet K. Aulakh, Elizabeth D. Thompson, Elizabeth M. Jaffee, Jennifer N. Durham, Cynthia L. Sears, Dung T. Le, Luis A. Díaz, Drew M. Pardoll, Hao Wang, Franck Housseau, Robert A. Anders	2019	32
5	Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer Clinical Cancer Research ·Megan Greally, Joanne F. Chou, Walid K. Chatila, Luis Yamil Ferrer, Marinela Capanu, Jaclyn F. Hechtman, Yaelle Tuvy, Ritika Kundra, Foysal Daian, Marc Ladanyi, David P. Kelsen, David H. Ilson, Michael F. Berger, Laura H. Tang, David B. Solit, Luis A. Díaz, Nikolaus Schultz, Yelena Y. Janjigian, Geoffrey Y. Ku	2019	75
6	The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA Clinical Cancer Research ·Sonya Parpart-Li, Bjarne R. Bartlett, Maria Popoli, Vilmos Adleff, Laura Tucker, Rebecca Steinberg, Andrew Georgiadis, François Payan, Julie R. Brahmer, J Armenta, Ilene Browner, Daniel A. Laheru, Victor E. Velculescu, Mark Sausen, Luis A. Díaz	2016	145
7	Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment Clinical Cancer Research ·Elena Garralda, Keren Paz, Pedro P. López‐Casas, Siân Jones, Amanda Katz, Lisa Kann, Fernando López‐Ríos, Francesca Sarno, Fátima Al‐Shahrour, David Vásquez, Elizabeth Bruckheimer, Samuel V. Angiuoli, Antonio Calles, Luis A. Díaz, Victor E. Velculescu, Alfonso Valencia, David Sidransky, Manuel Hidalgo	2014	107
8	TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine Cancer Research ·Isaac Kinde, Enrico Munari, Sheila F. Faraj, Ralph H. Hruban, Mark Schoenberg, Trinity J. Bivalacqua, Mohamad E. Allaf, Simeon Springer, Yuxuan Wang, Luis A. Díaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, George J. Netto	2013	200
9	Genetically Defined Subsets of Human Pancreatic Cancer Show Unique In Vitro Chemosensitivity Clinical Cancer Research ·Yunfeng Cui, Jacqueline A. Brosnan‐Cashman, Amanda L. Blackford, Surojit Sur, Ralph H. Hruban, Kenneth W. Kinzler, Bert Vogelstein, Anirban Maitra, Luis A. Díaz, Christine A. Iacobuzio–Donahue, James R. Eshleman	2012	54
10	The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers Nature ·Luis A. Díaz, Richard T. Williams, Jian Wu, Isaac Kinde, J. Randolph Hecht, Jordan Berlin, Benjamin Allen, Ivana Božić, Johannes G. Reiter, Martin A. Nowak, Kenneth W. Kinzler, Kelly S. Oliner, Bert Vogelstein Hit paper breakdown →	2012	1290
11	DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors Science ·Yuchen Jiao, Chanjuan Shi, Barish H. Edil, Roeland F. de Wilde, David S. Klimstra, Anirban Maitra, Richard D. Schulick, Laura H. Tang, Christopher L. Wolfgang, Michael A. Choti, Victor E. Velculescu, Luis A. Díaz, Bert Vogelstein, Kenneth W. Kinzler, Ralph H. Hruban, Nickolas Papadopoulos Hit paper breakdown →	2011	1244
12	Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis Clinical Cancer Research ·Matthias Holdhoff, Kerstin Schmidt, Frank Diehl, Jean-René Trochet, Philipp Angenendt, Katharine Romans, Daniel L. Edelstein, Michael Torbenson, Kenneth W. Kinzler, Bert Vogelstein, Michael A. Choti, Luis A. Díaz	2011	36
13	Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development Science Translational Medicine ·Jian Wu, Hanno Matthaei, Anirban Maitra, Marco Dal Molin, Laura D. Wood, James R. Eshleman, Michael Goggins, Marcia Irene Canto, Richard D. Schulick, Barish H. Edil, Christopher L. Wolfgang, Alison P. Klein, Luis A. Díaz, Peter J. Allen, C. Max Schmidt, Kenneth W. Kinzler, Nickolas Papadopoulos, Ralph H. Hruban, Bert Vogelstein Hit paper breakdown →	2011	562
14	Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma Science ·Siân Jones, Tian‐Li Wang, Ie‐Ming Shih, Tsui-Lien Mao, Kentaro Nakayama, Richard B.S. Roden, Ruth Glas, Dennis J. Slamon, Luis A. Díaz, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Nickolas Papadopoulos Hit paper breakdown →	2010	923
15	Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells Science ·Jihye Yun, Carlo Rago, Ian Cheong, Roy Garner, Philipp Angenendt, Harith Rajagopalan, Kerstin Schmidt, James K. V. Willson, Sandy D. Markowitz, Shibin Zhou, Luis A. Díaz, Victor E. Velculescu, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos Hit paper breakdown →	2009	724
16	A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53 Proceedings of the National Academy of Sciences ·Surojit Sur, Raymond Pagliarini, Fred Bunz, Carlo Rago, Luis A. Díaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos	2009	230
17	p38MAPK inhibition prevents disease in pemphigus vulgaris mice Proceedings of the National Academy of Sciences ·Paula Berkowitz, Peiqi Hu, Simon Warren, Zhi Liu, Luis A. Díaz, David S. Rubenstein	2006	179
18	A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs Science ·Ian Cheong, Xin Huang, Chetan Bettegowda, Luis A. Díaz, Kenneth W. Kinzler, Shibin Zhou, Bert Vogelstein	2006	136
19	The colorectal microRNAome Proceedings of the National Academy of Sciences ·Jordan M. Cummins, Yiping He, Rebecca Leary, Roy Garner, Luis A. Díaz, Tobias Sjöblom, Omer Barad, Zvi Bentwich, Anna E. Szafranska, Emmanuel Labourier, Christopher K. Raymond, Brian S. Roberts, Hartmut Juhl, Kenneth W. Kinzler, Bert Vogelstein, Victor E. Velculescu Hit paper breakdown →	2006	757
20	Synergy between a plasminogen cascade and MMP-9 in autoimmune disease Journal of Clinical Investigation ·Zhi Liu, Ning Li, Luis A. Díaz, Michael T. Shipley, Robert M. Senior, Zena Werb	2005	84

About Luis A. Díaz

Luis A. Díaz is a scholar working on Pathology and Forensic Medicine, Genetics, Rheumatology, Cancer Research and Oncology, having authored 419 papers that have together received 40.3k indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (170 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (108 papers), Urticaria and Related Conditions (89 papers), Genetic factors in colorectal cancer (78 papers), Cancer Genomics and Diagnostics (71 papers), Colorectal Cancer Treatments and Studies (57 papers), Cancer Immunotherapy and Biomarkers (35 papers) and Pancreatic and Hepatic Oncology Research (28 papers). The work is most often cited by research in Cancer Research (13.9k citations), Pathology and Forensic Medicine (14.1k citations), Genetics (7.1k citations), Oncology (14.6k citations) and Rheumatology (5.7k citations). Luis A. Díaz has collaborated with scholars based in United States, Brazil and Japan. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Nickolas Papadopoulos, Shibin Zhou, Alberto Bardelli, Grant J. Anhalt, George J. Giudice, Ramzy S. Labib and Zhi Liu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Investigative Dermatology, Journal of Clinical Investigation, The Journal of Immunology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact